The DOI matches its Crossref record; 251 of the 257 references it cites were found in a registry or an index.
Androgen Therapy in Women: A Reappraisal: An Endocrine Society Clinical Practice Guideline
Open accessAbstract
OBJECTIVE: To update practice guidelines for the therapeutic use of androgens in women. PARTICIPANTS: A Task Force appointed by the Endocrine Society, American Congress of Obestricians and Gynecologists (ACOG), American Society for Reproductive Medicine (ASRM), European Society of Endocrinology (ESE), and International Menopause Society (IMS) consisting of six experts, a methodologist, and a medical writer. EVIDENCE: The Task Force commissioned two systematic reviews of published data and considered several other existing meta-analyses and trials. The GRADE methodology was used; the strength of a recommendation is indicated by a number "1" (strong recommendation, we recommend) or "2" (weak recommendation, we suggest). CONSENSUS PROCESS: Multiple e-mail communications and conference calls determined consensus. Committees of the Endocrine Society, ASRM, ACOG, ESE, and IMS reviewed and commented on the drafts of the guidelines. CONCLUSIONS: We continue to recommend against making a diagnosis of androgen deficiency syndrome in healthy women because there is a lack of a well-defined syndrome, and data correlating androgen levels with specific signs or symptoms are unavailable. We recommend against the general use of T for the following indications: infertility; sexual dysfunction other than hypoactive sexual desire disorder; cognitive, cardiovascular, metabolic, or bone health; or general well-being. We recommend against the routine use of dehydroepiandrosterone due to limited data concerning its effectiveness and safety in normal women or those with adrenal insufficiency. We recommend against the routine prescription of T or dehydroepiandrosterone for the treatment of women with low androgen levels due to hypopituitarism, adrenal insufficiency, surgical menopause, pharmacological glucocorticoid administration, or other conditions associated with low androgen levels because there are limited data supporting improvement in signs and symptoms with therapy and no long-term studies of risk. Evidence supports the short-term efficacy and safety of high physiological doses of T treatment of postmenopausal women with sexual dysfunction due to hypoactive sexual desire disorder. Importantly, endogenous T levels did not predict response to therapy. At present, physiological T preparations for use in women are not available in many countries including the United States, and long-term safety data are lacking. We recommend that any woman receiving T therapy be monitored for signs and symptoms of androgen excess. We outline areas for future research. Ongoing improvement in androgen assays will allow a redefinition of normal ranges across the lifespan; this may help to clarify the impact of varying concentrations of plasma androgens on the biology, physiology, and psychology in women and lead to indications for therapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Shaw, L. J., Bairey Merz, C. N., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0425 · Cited by 427
RetractedDiagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,842
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
The Endogenous Hormones and Breast Cancer Collaborative Group (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.8.606 · Cited by 1,799
ORENTREICH, N., BRIND, J. L., RIZER, R. L., & VOGELMAN, J. H. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-551 · Cited by 1,349
Atkins, D., Eccles, M., Flottorp, S., Guyatt, G. H., Henry, D., Hill, S., Liberati, A., O'Connell, D., Oxman, A. D., Phillips, B., et al. (2004) · BMC Health Services Research · doi:10.1186/1472-6963-4-38 · Cited by 1,235
ANDERSON, D. C. (1974) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1974.tb03298.x · Cited by 1,127
Södergard, R., Bäckström, T., Shanbhag, V., & Carstensen, H. (1982) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(82)90038-3 · Cited by 1,080
Flagged first, then by citations
6 of the 257 references couldn’t be matched to a known paper.
Research works printed but not linked: 6
- [13]13. Braunstein GD, Reitz RE, Buch A, Schnell D, Caulfield MP. Tes- tosterone reference ranges in normally cycling healthy premeno- pausal women. J Sex Med. 2011;8:2924 -2934.
- [28]28. Ly LP, Sartorius G, Hull L, et al. Accuracy of calculated free tes- tosterone formulae in men. Clin Endocrinol (Oxf). 2010;73:382- 388.
- [31]31. Rosner W. An extraordinarily inaccurate assay for free testoster- one is still with us. J Clin Endocrinol Metab. 2001;86:2903.
- [179]179. Rhodes JC, Kjerulff KH, Langenberg PW, Guzinski GM. Hyster- ectomy and sexual functioning. JAMA. 1999;282:1934 -1941.
- [182]182. Snabes MC, Zborowski J, Simes S. Libigel (testosterone gel) does not differentiate from placebo therapy in the treatment of hypo- active sexual desire in postmenopausal women. J Sex Med. 2012; 3:171.
- [195]195. Anderson KE, Sellers TA, Chen PL, Rich SS, Hong CP, Folsom AR. Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa. Cancer. 1997;79:494 -499.
Cited by
Sorted by citations
Items 201–300 of 357
Update on menopausal hormone therapy
Ensarı, T. A., & Pal, L. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000207 · Cited by 3
Roeca, C. M., Al-Safi, Z. A., & Santoro, N. F. (2015) · Cited by 3
Self-citationStute, P., Habermann, G., Kiesel, L., Zepelin, H. H., & de Arriba, S. G. (2016) · Clinical Phytoscience · doi:10.1186/s40816-016-0015-6 · Cited by 3
Weibliche Sexualität und sexuelle Störungen
Leeners, B. (2017) · Der Gynäkologe · doi:10.1007/s00129-016-4007-x · Cited by 3
Hughes, I. A., & Chatterjee, K. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00105-0 · Cited by 3
Female Sexual Function and Dysfunction
Kling, J. M., & Thomas, H. N. (2020) · Springer eBooks · doi:10.1007/978-3-030-50695-7_9 · Cited by 3
Vignozzi, L., & Maseroli, E. (2020) · Endocrinology · doi:10.1007/978-3-030-03594-5_6-2 · Cited by 3
Granville, L. J., Brent, G. A., & Pregler, J. P. (2018) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15537 · Cited by 3
Sexual Interest, Arousal Disorder in Women
Brotto, L. A., & Jabs, F. (2020) · Springer eBooks · doi:10.1007/978-3-319-59531-3_56-1 · Cited by 3
Review of Adrenal Androgen Synthesis, Hypersecretion, and Blockade
Olson, P., & Ristau, B. T. (2025) · Urologic Clinics of North America · doi:10.1016/j.ucl.2025.01.004 · Cited by 2
Sex hormones and sexual health in chronic kidney disease before and after kidney transplantation
Lobo, A. S., Vaughan, L. E., Ainsworth, A. J., Felt, M., Elali, I., Arriola‐Montenegro, J., Garovic, V. D., & Kattah, A. G. (2026) · Journal of Nephrology · doi:10.1093/joneph/aajaf022 · Cited by 2
Xu, H., Zhang, H., Yang, R., Xie, X., Cao, Z., Zhao, Y. (., Lin, H., Lu, D., Bischoff, F. Z., Zhang, X., et al. (2026) · The Innovation Nutrition · doi:10.59717/j.xinn-nutri.2026.100004 · Cited by 2
Treatment Approaches to Sexual Dysfunction in Late Life
Maruca-Sullivan, P. E., Kleinfeld, S. A., & Wilkins, K. M. (2018) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-018-0147-z · Cited by 2
Linda, V. P., & Maseroli, E. (2020) · Endocrinology · doi:10.1007/978-3-030-03594-5_6-1 · Cited by 2
Martín, M. A. A.-S., & Gallardo-González, R. P. (2022) · Revista chilena de obstetricia y ginecología · doi:10.24875/rechog.m21000039 · Cited by 2
Unerwünschte Wirkungen von Opioiden, Antidepressiva und Antikonvulsiva auf Sexualhormone
Wirz, S., Schenk, M., & Kieselbach, K. (2022) · Der Schmerz · doi:10.1007/s00482-022-00655-9 · Cited by 2
Sex Steroid Levels in Women With Hypopituitarism: A Case-controlled Observational Study
Olivius, C., Landin‐Wilhelmsen, K., Ohlsson, C., POUTANEN, M. H., Trimpou, P., Olsson, D. S., Johannsson, G., & Tivesten, Å. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae197 · Cited by 2
Warchała, A., Madej, P., Kochanowicz, M., & Krzystanek, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13082227 · Cited by 2
Sexual Desire and Pharmacologic Management
Rowen, T. S., & Simon, J. A. (2024) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2024.03.004 · Cited by 3
Menopausal hormone treatments and risk of cardiovascular diseases: modern view
Ilovayskaya, I. (2018) · GYNECOLOGY · doi:10.26442/2079-5696_2018.4.40-43 · Cited by 2
From Primary Hypergonadotropic Amenorrhea to “POI”: Aetiology and Therapy
Bruni, V., Bucciantini, S., & Ambroggio, S. (2017) · ISGE series · doi:10.1007/978-3-319-41433-1_7 · Cited by 2
Star-Weinstock, M., & Dey, S. (2019) · Clinical mass spectrometry · doi:10.1016/j.clinms.2019.05.001 · Cited by 2
Antiandrogene Wirkungen von Opioiden
Wirz, S. (2021) · Schmerzmedizin · doi:10.1007/s00940-021-3226-y · Cited by 2
Management of Sexual Dysfunctions
Ghidei, L. A., Hosseinzadeh, P., & Woodard, T. L. (2023) · Springer eBooks · doi:10.1007/978-3-319-17002-2_52-2 · Cited by 2
Strokovna stališča Slovenskega združenja za reproduktivno medicino (SZRM) o menopavzni medicini
Franić, D., Pinter, B., Vlaisavljević, V., Srnovršnik, T., Šabović, M., Starčević, J. N., Simetinger, G., Reljič, M., Knez, J., Geršak, K., et al. (2024) · Slovenian Medical Journal · doi:10.6016/zdravvestn.3512 · Cited by 2
Considerações sobre hormônios e sexo / Considerations on hormones and sex
Lima, S. M. R. R. (2021) · Arquivos Médicos dos Hospitais e da Faculdade de Ciências Médicas da Santa Casa de São Paulo · doi:10.26432/1809-3019.2021.66.015 · Cited by 1
Evaluation of the effectiveness of hormone therapy in patients with premature ovarian insufficiency
Titchenko, Y. P., Kruchinina, E. V., Владиславовна, Т. Е., Меньшикова, Н. С., Ovchinnikova, V. V., & Yarygina, Y. T. A. (2025) · Russian Bulletin of Obstetrician-Gynecologist · doi:10.17116/rosakush20252504186 · Cited by 1
Pilnik, S., Belardo, A., Marchesan, L. B., Camero-Lascano, A., Martín, M. A.-S., Elizalde-Cremonte, A., Ojeda, E., Alejandro Manzur, Y., & Chedraui, P. A. (2025) · Climacteric · doi:10.1080/13697137.2025.2548805 · Cited by 2
Hussain, M. R., Wu, S., Saab, D., Digbeu, B. D. E., Abdelgadir, O., Hernández‐Pérez, J. G., Torres‐Sánchez, L., Leonard, T., Cano, M. Á., Kuo, Y., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18091413 · Cited by 1
Testosterone Pellets in Women: Revisiting Safety and Clinical Outcomes
Viana, D. P. D. C., Jacobsen, L., Gabriel, L. H., Correia, E. L. D. S., Fernandes, D. D. M., Nagel, M. L., & Comin, A. (2025) · Cureus · doi:10.7759/cureus.94442 · Cited by 1
Depressive disorders in women during the menopausal transition and menopause
Titchenko, Y. P., Kruchinina, E. V., Ovchinnikova, V. V., Tsar’kova, A. V., & Yarygina, Y. T. A. (2025) · Russian Bulletin of Obstetrician-Gynecologist · doi:10.17116/rosakush20252505141 · Cited by 1
Midlife women's sexual health: from silent struggle to scientific priority
Gordon, J. L., & Brennand, E. A. (2025) · The Lancet Obstetrics Gynaecology & Women s Health · doi:10.1016/j.lanogw.2025.100059 · Cited by 1
Hunter, M., Coig, R., Risler, L. J., Patton, K. K., Narla, R. R., Greene, D. N., Burke, A. K., Micks, E., Hébert, M. F., & Cirrincione, L. R. (2025) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.70093 · Cited by 1
Dajani, A.-H. J., Liu, T. P., Araujo-Espinoza, G., Muy, K. B., Cope, S., Jones, K. J., & Kremen, T. J. (2026) · Orthopaedic Journal of Sports Medicine · doi:10.1177/23259671261430731 · Cited by 1
Management of Symptoms During the Menopausal Transition
Giannini, A., Genazzani, A. R., & Simoncini, T. (2015) · ISGE series · doi:10.1007/978-3-319-23865-4_19 · Cited by 1
The Case for Androgens in Menopausal Women: When and How?
Huang, G. T.-W., & Basaria, S. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-42451-4_10 · Cited by 1
Die „therapieresistente“ Libidostörung der Frau
Sarasin, E., & Leeners, B. (2018) · Gynäkologische Endokrinologie · doi:10.1007/s10304-018-0178-y · Cited by 1
Intravaginal DHEA for the Treatment of Vulvovaginal Atrophy, Intracrinology at Work
Labrie, F. (2018) · ISGE series · doi:10.1007/978-3-319-63540-8_24 · Cited by 1
Findeklee, S., Sklavounos, P., Stotz, L., Sima, R., Iordache, I., Spüntrup, C., Kasoha, M., Thangarajah, F., Solomayer, E., & Radosa, J. C. (2019) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-019-05079-y · Cited by 1
Endokrine Aspekte bei Libidostörungen
Keck, C. (2019) · gynäkologie + geburtshilfe · doi:10.1007/s15013-019-1768-z · Cited by 1
Overview on Hormonal Replacement Therapy in Menopause
Alanazi, S. A. A., Alatawi, A. M. E., Alhwaiti, A. S. A., Alrashidi, A. S. A., Alanazi, G., Alfaqiri, M. K. S., Alenezi, R. N. A., albalawi, W. A., Alharbi, L. H. J., & Alharbi, G. A. H. (2021) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2021/v33i39a32152 · Cited by 1
Tratamento das disfunções sexuais no consultório do ginecologista
Lara, L. A. D. S., Lopes, G. P., Scalco, S. C. P., Vale, F. B. C., Rufino, A. C., Troncon, J. K., Abdo, C. H. N., Serapião, J. J., & Aguiar, Y. (2019) · Femina · doi:10.61622/0100-7254472201901 · Cited by 1
Hormonal Regulation of Vaginal Mucosa
Kallak, T. K. (2015) · Cited by 1
Resolution of The II International Menopause Expert Forum
- (2021) · Reproductive Endocrinology · doi:10.18370/2309-4117.2021.60.77-84 · Cited by 1
Hoz, F. J. E. D. L. (2022) · Revista Internacional de Andrología · doi:10.1016/j.androl.2021.09.002 · Cited by 2
Dehydroepiandrosterone sulfate supplementation in health and diseases
Jethwani, P., Rastogi, A., & Shukla, R. K. G. (2023) · World Journal of Meta-Analysis · doi:10.13105/wjma.v11.i4.102 · Cited by 1
Maseroli, E., Alfaroli, C., & Vignozzi, L. (2023) · Springer eBooks · doi:10.1007/978-3-031-31501-5_20 · Cited by 1
Hoz, F. J. E. D. L. (2024) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.11.2.802 · Cited by 2
Gieles, N. C., Kroon, M. A. G. M., Both, S., Heijboer, A. C., Kreukels, B. P. C., & den Heijer, M. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae103 · Cited by 1
McGlacken-Byrne, S. M., Gunn, H. M., & Simpson, H. (2024) · Endocrinology · doi:10.1007/978-3-030-23709-7_29 · Cited by 1
Doping Status of DHEA Treatment for Female Athletes with Adrenal Insufficiency
Handelsman, D. J., Matsumoto, A. M., & GERRARD, D. F. (2016) · Clinical Journal of Sport Medicine · doi:10.1097/jsm.0000000000000300 · Cited by 1
Menopausal hormone therapy: Benefits and different forms
Kutlesic, R. M., Popović, J., Stefanović, M., Vukomanović, P., Andrić, A., & Milošević, J. (2016) · Medicinski pregled · doi:10.2298/mpns1608247k · Cited by 1
Sexual and Reproductive Dysfunction in Young Female Cancer Patients
Chappell, N. R., & Woodard, T. L. (2017) · Current Sexual Health Reports · doi:10.1007/s11930-017-0098-1 · Cited by 1
Dellenborg, L., Persson, J. T., Ung, E. J., Johannsson, G., Olofsson, A.-C., & Björkman, I. (2020) · Sexuality and Disability · doi:10.1007/s11195-020-09625-4 · Cited by 1
Early menopause: diagnosis and management
Glenn, T. L., & Kallen, A. N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822288-1.00009-9 · Cited by 1
Care of the Patient with Sexual Concerns
Leanza, F., & Maritato, A. (2022) · Springer eBooks · doi:10.1007/978-3-030-54441-6_65 · Cited by 1
Androgen Therapy in Women with Testosterone Insufficiency: Looking Back and Looking Ahead
Traish, A. M., & Morgentaler, A. (2022) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2021.0030 · Cited by 1
Hipopituitarismo. Panhipopituitarismo
Torres, N. P., Trifu, D. S., Montes, M. P. G., & Sánchez, E. A. (2016) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2016.06.022 · Cited by 1
Pagnussatt, L. C., Fabiani, T. M., Andrade, G. H., Zeni, M., & Lutinski, J. A. (2022) · Editora Conhecimento Livre eBooks · doi:10.37423/220906558 · Cited by 1
The Adaptive Value of Women’s Orgasm
Welling, L. L. M., Mitchell, V. E., Lunge, J., & Orille, A. C. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108943567.014 · Cited by 1
Management of Sexual Dysfunctions
Ghidei, L. A., Hosseinzadeh, P., & Woodard, T. L. (2023) · Springer eBooks · doi:10.1007/978-3-031-14881-1_52 · Cited by 1
Bachmann, G. A., & Phillips, N. A. (2017) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000979 · Cited by 1
Hypopituitarism, Causes, Diagnosis, Management and Mortality
Fountas, A., & Karavitaki, N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64277-0 · Cited by 1
Mesquita, A. M. M. (2003) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/yz5a-jv53 · Cited by 1
Unravelling the link between insulin resistance and androgen excess
O’Reilly, M. (2015) · University of Birmingham Institutional Research Archive (University of Birmingham)
von Wolff, M., & Stute, P. (2018) · Gynäkologische Endokrinologie · doi:10.1007/s10304-018-0185-z
Endocrine Society Updates Guidelines on Androgen Therapy in Women
Herman, P. F. W. A. O., & Kaunitz, A. M. (2014) · Journal watch · doi:10.1056/nejm-jw.na36003
Care of the Patient with Sexual Concerns
Leanza, F., & Maritato, A. (2015) · Springer eBooks · doi:10.1007/978-1-4939-0779-3_65-1
Testosterone Therapy: Oral Androgens
Kalinchenko, S. Y., Tyuzikov, I. A., Mskhalaya, G. J., & Tishova, Y. (2017) · Springer eBooks · doi:10.1007/978-3-319-46086-4_10
Benefits and Adverses Effects of Testosterone Therapy
Costa, E. M. F., Amato, L. G. L., & Silveira, L. F. G. (2017) · Springer eBooks · doi:10.1007/978-3-319-46086-4_13
Androgens in postmenopausal women
Davis, S. R. (2018) · Gynäkologische Endokrinologie · doi:10.1007/s10304-018-0187-x
Self-citationPharmacosexology: Psychiatric Side Effects of Drugs for the Treatment of Sexual Dysfunction
Abdo, C. H. N. (2018) · Trends in andrology and sexual medicine · doi:10.1007/978-3-319-68306-5_20
Urinary incontinence in women: some aspects of the problem by the data of social questioning
Yatsyna, O. I. (2018) · Urologiya · doi:10.26641/2307-5279.22.2.2018.135453
The Use of DHEA to Improve Oocyte Quality
Kroon, B. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316756744.011
Isidori, A. M., Rowen, T. S., & Shindel, A. W. (2016) · Sexual Medicine · doi:10.1016/j.esxm.2016.02.002
BIOCHEMICAL MARKERS OF HYPERANDROGENISM IN CONDITIONS OF INCREASED EXPOSURE OF MANGANESE AND NICKEL
Gunkov, S. V. (2016) · Clinical & experimental pathology · doi:10.24061/1727-4338.xv.2.56.2016.13
Yatsyna, O. I., & Єфименко, О. О. (2019) · Health of Man · doi:10.30841/2307-5090.1.2019.172794
Hipoaktif cinsel istek bozukluğunun yönetimi
Tekın, Y. B., & Erin, K. B. (2020) · Türk Kadın Sağlığı ve Neonatoloji Dergisi · doi:10.46969/etlikzubeyde.736664
Barrera, F. J., Raygoza-Cortez, K., García-Leal, M., Brito, J. P., Ospina, N. S., & Rodríguez‐Gutiérrez, R. (2021) · Endocrine · doi:10.1007/s12020-020-02592-y · Cited by 1
The Role of Testosterone in Menopause Management: A Review of Literature
Manalo, E. M., Irabon, I. S., & Fajutagana, S. S. (2021) · Fertility & Reproduction · doi:10.1142/s2661318221500110
Directive clinique no 422d : Ménopause et sexualité
Wolfman, W., Krakowsky, Y., & Fortier, M. P. (2021) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2021.09.008
Crimer, N., & Terrasa, S. (2021) · Evidencia actualizacion en la práctica ambulatoria · doi:10.51987/evidencia.v24i4.6961
Influence of androgen deficiency on the endometrium structure in women of reproductive age
Дем’яненко, Л. В., Семенюк, Л. М., & Yuzvenko, Т. Y. (2021) · Clinical endocrinology and endocrine surgery · doi:10.30978/cees-2021-2-40
Testosterone Therapy for Women: Still Many Questions to be Answered
Benetti‐Pinto, C. L. (2022) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0042-1742619
Yasmin, E., & Conway, G. S. (2022) · doi:10.1093/med/9780198870197.003.0162
Chapter on Testosterone Therapy
DeLucia, C. (2022) · Springer eBooks · doi:10.1007/978-981-16-1743-0_14
Kotova, A., Bulgakova, S. V., Melikova, A. V., & Romanchuk, N. (2021) · Bulletin of Science and Practice · doi:10.33619/2414-2948/65/15
Bachelot, A. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-74372-6.00035-7
Care of the Patient with Sexual Concerns
Leanza, F., & Maritato, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-04414-9_65
Testosterone therapy for menopausal women
(2017) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2017.5.0481
Maggio, M. G., Lauretani, F., & Ceda, G. P. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780198701590.003.0149
Семенюк, Л. М., & Дем’яненко, Л. В. (2020) · Репродуктивное здоровье Восточная Европа · doi:10.34883/pi.2020.10.3.007
Neues und praktisch Relevantes aus der gynäkologischen Endokrinologie und Reproduktionsmedizin
von Wolff, M., & Stute, P. (2016) · Gynäkologische Endokrinologie · doi:10.1007/s10304-016-0059-1
Care of the Patient with Sexual Concerns
Leanza, F., & Maritato, A. (2020) · Springer eBooks · doi:10.1007/978-1-4939-0779-3_65-2
Andrologierelevante Gynäkologie
Knuth, U. A. (2021) · Springer Reference Medizin · doi:10.1007/978-3-662-61904-9_41-1
КЛИНИКО-ПАТОГЕНЕТИЧЕСКИЕ АСПЕКТЫ ПРЕЖДЕВРЕМЕННОЙ И РАННЕЙ МЕНОПАУЗЫ. ПУТИ КОРРЕКЦИИ
Юлдашевна, Н. Д., Талмасовна, К. Д., & Kadirovna, M. T. (2022) · Medical science of Uzbekistan · doi:10.56121/2181-3612-2022-1-11-15
Wierman, M. E. (2022) · Springer eBooks · doi:10.1007/978-3-030-99918-6_23
Self-citationEmerging drug delivery in the treatment of hyperpituitarism and hypopituitarism
Arora, V., Kabra, A., Puri, R., Vyas, G. K., Dua, K., & Dureja, H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99616-7.00004-9
Metadata
- Authors
- Wierman, M. E., Arlt, W., Basson, R., Davis, S. R., Miller, K. K., Murad, M. H., Rosner, W., & Santoro, N.
- Affiliations
- University of British Columbia (CA)
- University of Birmingham (GB)
- Veterans Health Administration (US)
- Massachusetts General Hospital (US)
- Mayo Clinic (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2014-10
- Volume
- 99
- Issue
- 10
- Pages
- 3489-3510
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2169638329
- Semantic Scholar
- 0ab9fec7488d4092d18727dbe6ea5d548da84c6e
- Cited by
- 363
- References
- 257
- Citations by year
- 2026: 18 · 2025: 24 · 2024: 27 · 2023: 22 · 2022: 52 · 2021: 46 · 2020: 28 · 2019: 25 · 2018: 31 · 2017: 27 · 2016: 34 · 2015: 25 · 2014: 3
- FWCI
- 23.88
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- androgen therapy, women, testosterone, dehydroepiandrosterone, hypoactive sexual desire disorder, postmenopausal women, adrenal insufficiency, hypopituitarism, surgical menopause, hyperandrogenism, infertility, sexual dysfunction, bone health, cardiovascular risk, treatment safety
- MeSH terms
- Contraindications, Androgens, Endocrinology, Female, Humans, Hypopituitarism, Societies, Medical, Practice Guidelines as Topic, Evidence-Based Medicine, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
